Dr. Michel S. Makaroun, MD

Dr. Makaroun practices at UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Dr. Makaroun's NPI, 1689648792, was assigned on February 15, 2006. Dr. Makaroun graduated from American University of Beirut Faculty of Medicine in 1978. Dr. Makaroun holds Pennsylvania license MD025612E.

Dr. Makaroun's primary practice is UPMC Presbyterian, at 200 Lothrop Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 647-2345.

Dr. Makaroun's primary practice is UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Dr. Makaroun is also affiliated with Select Specialty Hospital - Pittsburgh / UPMC. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Makaroun to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Makaroun practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Makaroun's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Makaroun is board certified in vascular surgery by the American Board of Surgery. Dr. Makaroun is licensed in Pennsylvania.

Dmand AI lists arterial blot clot /embolism, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, heart device and aorta surgery, leg revascularization and peripheral vascular disease among the conditions Dr. Makaroun treats.

CMS data shows 235 Medicare services from Dr. Makaroun across 10 procedure codes in 2024, for 220 Medicare patients. Medicare paid $19,632 for them. Every service was in an office.

CMS counts 220 Medicare patients who saw Dr. Makaroun in 2024. The largest group is 65 to 74, with 115 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Makaroun's median patient age at 73, with 33% women.

In 2024, Dr. Makaroun wrote 132 Medicare Part D claims for 43 patients. 71% of them were for generic drugs. CMS names the drug for 118 of them, across 6 drugs with 11 or more claims each, at $24,892 in total drug cost. In 2023, CMS named 49 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Makaroun for performance year 2024, reported as part of a group. Dr. Makaroun accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 224 papers to Dr. Makaroun, published from 2002 to 2025. 2016 was the busiest year, with 18. The most frequent topics are Endovascular Procedures, Blood Vessel Prosthesis Implantation and Aortic Aneurysm, Abdominal. Dr. Makaroun has published most often in J Vasc Surg. Dr. Makaroun's most frequent co-authors are Rabih A. Chaer, Efthymios Avgerinos and Luke Keith Marone, MD.

Dmand AI links Dr. Makaroun to 4 clinical trials. 1 is still active or recruiting. Conditions studied include Aortic Aneurysm, Abdominal, Aortic Aneurysm and Carotid Stenosis. Rabih A. Chaer sponsors the most, 2.

CMS Open Payments shows 269 general payments to Dr. Makaroun from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 79% of the total. W. L. Gore & Associates, Inc. paid the most, $134,488.

Dmand AI lists 1 award for Dr. Makaroun, most recently CMS Stage 1 EHR in 2011.

Dr. Makaroun graduated from American University of Beirut Faculty of Medicine in 1978.

Dr. Makaroun is in network with 16 carriers, including Aetna, United Healthcare and Cigna. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.